CYCN 株価推移チャート
CYCN 財務
Cyclerion Therapeutics Inc
$6.15
-3.6%
$-0.22
終値： Apr 02, 16:00:00 GMT-4
$5.96
-2.93%
$-0.18
アフターマーケット：Apr 02, 18:34:52 GMT-4
戻る
Cyclerion Therapeutics Inc (CYCN) 財務
主要データ
前終値
$6.38
始値
$4.94
当日レンジ
$4.65 - $6.74
52週レンジ
$1.02 - $8.48
取引高
11.1M
平均取引高
5.8M
配当利回り
--
1株当たり利益(TTM)
-0.76
時価総額
$23.4M
CYCNとは何ですか？
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. The company is headquartered in Cambridge, Massachusetts and currently employs 1 full-time employees. The company went IPO on 2019-03-18. The firm is focused on building a pipeline with therapeutics to treat certain neuropsychiatric diseases. The company is focused on an individualized therapy for treatment-resistant depression (TRD) - a condition with significant unmet medical need. Its assets include Olinciguat and Praliciguat. The firm has entered into an exclusive license option agreement for its vascular soluble guanylate cyclase (sGC) stimulator, olinciguat. Praliciguat is an oral, once-daily, systemic sGC stimulator that is licensed to Akeibia Therapeutics, Inc and is being advanced in rare kidney disease.